Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Uremic Toxins and Health Outcomes in Chronic Kidney Disease

Studies whether waste substances in the blood relate to illness and death in kidney disease.

Plain-language title generated from the registry record
Registry title: Uremic Toxins and Outcomes in Chronic Kidney Disease

Key facts

Where
Shanghai, ChinaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with chronic kidney disease diagnosed by a doctor under the K/DOQI criteria. It studies how toxins in the blood relate to complications and death.

Age
18 years or older
Sex
All sexes can join
Disease stage
Chronic kidney disease diagnosed clinically, according to K/DOQI criteria

Main reasons for not taking part

  • Acute kidney injury
  • History of kidney injury less than 3 months ago
  • Cancer (malignancy)
  • Pregnancy
  • Incomplete clinical data

Read by machine on 9 November 2026.

Where in China

  • Shanghai Ninth People's HospitalShanghai, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Trial code
NCT03711617
Record updated
3 December 2024
Original description
The aim of this cohort study is:Read full original descriptionShow less

The Association Between Uremic Toxins and Outcomes and Comorbidities in Patients With CKD

The aim of this cohort study is:

To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.

Inclusion: age ≥18 years old; clinically diagnosed with chronic kidney disease, according K/DOQI criteria.

Exclusion: history of kidney injury <3 months; malignancy; acute kidney injury; pregnancy; incomplete clinical data.

ClinicalTrials.gov NCT03711617